These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37807322)

  • 21. Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
    Huyen NT; Prachayasittikul V; Chan-On W
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):397-405. PubMed ID: 27107220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus.
    Saengboonmee C; Sorin S; Sangkhamanon S; Chomphoo S; Indramanee S; Seubwai W; Thithuan K; Chiu CF; Okada S; Gingras MC; Wongkham S
    World J Gastroenterol; 2023 Jul; 29(28):4416-4432. PubMed ID: 37576707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.
    Pan S; Hu Y; Gan L; Lai J; Zheng P; Zhang Y; Shuai L; Jiang Y; Chen M; Wang J; He Y
    Ann Hepatol; 2024; 29(2):101279. PubMed ID: 38123132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway.
    Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y
    Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 14-3-3ζ and aPKC-ι synergistically facilitate epithelial-mesenchymal transition of cholangiocarcinoma via GSK-3β/Snail signaling pathway.
    Yang Y; Liu Y; He JC; Wang JM; Schemmer P; Ma CQ; Qian YW; Yao W; Zhang J; Qi WP; Fu Y; Feng W; Yang T
    Oncotarget; 2016 Aug; 7(34):55191-55210. PubMed ID: 27409422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
    Menakongka A; Suthiphongchai T
    World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.
    Hong SM; Park CW; Cha HJ; Kwon JH; Yun YS; Lee NG; Kim DG; Nam HG; Choi KY
    Clin Exp Metastasis; 2013 Feb; 30(2):177-87. PubMed ID: 22875246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
    Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
    J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells.
    Saengboonmee C; Phoomak C; Supabphol S; Covington KR; Hampton O; Wongkham C; Gibbs RA; Umezawa K; Seubwai W; Gingras MC; Wongkham S
    Life Sci; 2020 Dec; 262():118548. PubMed ID: 33038372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. L-Fucose inhibits the progression of cholangiocarcinoma by causing microRNA-200b overexpression.
    Zhu B; Zheng J; Hong G; Bai T; Qian W; Liu J; Hou X
    Chin Med J (Engl); 2022 Dec; 135(24):2956-2967. PubMed ID: 36728287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PHD2 acts as an oncogene through activation of Ras/Raf/MEK/ERK and JAK1/STAT3 pathways in human hepatocellular carcinoma cells.
    Guo J; Lan Z
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):37-45. PubMed ID: 31852247
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
    Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
    Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of CXCR4 inhibits tumor cell proliferation and neural invasion in human hilar cholangiocarcinoma.
    Tan XY; Chang S; Liu W; Tang HH
    Gut Liver; 2014 Mar; 8(2):196-204. PubMed ID: 24672662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling.
    Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
    J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and clinical significance of interleukin-6 pathway in cholangiocarcinoma.
    Gu D; Zhao X; Song J; Xiao J; Zhang L; Deng G; Li D
    Front Immunol; 2024; 15():1374967. PubMed ID: 38881895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
    Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
    Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
    Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
    World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).
    Yang R; Song Y; Shakoor K; Yi W; Peng C; Liu S
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35302174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of phosphatase shatterproof 2 by evodiamine suppresses the proliferation and invasion of human cholangiocarcinoma.
    Zhu B; Zhao L; Liu Y; Jin Y; Feng J; Zhao F; Sun J; Geng R; Wei Y
    Int J Biochem Cell Biol; 2019 Mar; 108():98-110. PubMed ID: 30682488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.